Pfizer/BioNTech Covid jab may be offered to 12-year-olds in Europe from June

BioNTech submitting applications in US and Europe for vaccine to be available to those aged 12-15

BioNTech’s Covid-19 vaccine, jointly developed with Pfizer, should be available to 12- to 15-year-olds in Europe from June, the chief executive of the German company has said.

Uğur Şahin said BioNTech had submitted its application for emergency approval of vaccines for this age group in the US at the start of April, and next Wednesday would be ready to submit the application for approval by the European Medicines Agency.

Continue reading...

Coronavirus | The Guardian

Comments

Popular posts from this blog

Vaccine hesitant New Yorkers consider leaving the city as mandates take effect

Coronavirus live news: AstraZeneca reports vaccine shortfall to EU; Sydney hotel quarantine worker tests positive

One in six New York City workers remain unvaccinated after Friday deadline